Solicitation of Nominations for Membership on the Secretary's Advisory Committee on Human Research Protections; Correction, 20666 [2024-06362]

Download as PDF 20666 Federal Register / Vol. 89, No. 58 / Monday, March 25, 2024 / Notices paccarb on the Upcoming Meetings page. The meeting is scheduled to be held on May 21–22, 2024, from 9 a.m. to 4 p.m. ET (times are tentative and subject to change). The confirmed times and agenda items for the meeting will be posted on the website for the PACCARB at https://www.hhs.gov/paccarb when this information becomes available. Preregistration for attending the meeting is strongly suggested and should be completed no later than May 16, 2024. ADDRESSES: The meeting will be held inperson at the Westin Tyson’s Corner, 7801 Leesburg Pike, Falls Church, VA, 22043. The meeting will also be live streamed and can be accessed through a live webcast on the day of the meeting. Additional instructions regarding attending this meeting virtually will be posted at least one week prior to the meeting at: https://www.hhs.gov/ paccarb. DATES: khammond on DSKJM1Z7X2PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated Federal Officer, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, 1101 Wootton Parkway, Rockville, MD 20852. Phone: 202–746– 1512; Email: CARB@hhs.gov. SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB), established by Executive Order 13676, is continued by Section 505 of Public Law 116–22, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAIA). Activities and duties of the PACCARB are governed by the provisions of the Federal Advisory Committee Act (FACA), Public Law 92– 463, as amended (5 U.S.C. App.), which sets forth standards for the formation and use of federal advisory committees. The PACCARB shall advise and provide information and recommendations to the Secretary of Health and Human Services (Secretary) regarding programs and policies intended to reduce or combat antibioticresistant bacteria that may present a public health threat and improve capabilities to prevent, diagnose, mitigate, or treat such resistance. The PACCARB shall function solely for advisory purposes. Such advice, information, and recommendations may be related to improving: the effectiveness of antibiotics; research and advanced research on, and the development of, improved and innovative methods for VerDate Sep<11>2014 18:08 Mar 22, 2024 Jkt 262001 combating or reducing antibiotic resistance, including new treatments, rapid point-of-care diagnostics, alternatives to antibiotics, including alternatives to animal antibiotics, and antimicrobial stewardship activities; surveillance of antibiotic-resistant bacterial infections, including publicly available and up-to-date information on resistance to antibiotics; education for health care providers and the public with respect to up-to-date information on antibiotic resistance and ways to reduce or combat such resistance to antibiotics related to humans and animals; methods to prevent or reduce the transmission of antibiotic-resistant bacterial infections; including stewardship programs; and coordination with respect to international efforts in order to inform and advance the United States capabilities to combat antibiotic resistance. The focus of the May 21–22, 2024, meeting will be to deliberate and vote on the Global Antimicrobial Resistance Working Group report to the Secretary of Health and Human Services. The remainder of the public meeting will include updates on AMR in conflict zones, the environment, and the voice of the patient. The meeting agenda will be posted on the PACCARB website at https://www.hhs.gov/paccarb when it has been finalized. All agenda items are tentative and subject to change. Instructions regarding attending the meeting virtually will be posted at least one week prior to the meeting at: https:// www.hhs.gov/paccarb. Members of the public will have the opportunity to provide comments during the May meeting by pre-registering online at https://www.hhs.gov/paccarb; preregistration is required for participation in this session with limited spots available. Written public comments can also be emailed to CARB@hhs.gov by midnight May 14, 2024, and should be limited to no more than one page. All public comments received prior to May 14, 2024, will be provided to the PACCARB members. Additionally, companies or organizations working to combat antimicrobial resistance my share their innovation during the May meeting by pre-registering to speak during the meeting’s Innovation Spotlight. Pre-registration online at https://www.hhs.gov/paccarb is required for participation in this session, and limited spots are available. PO 00000 Dated: March 14, 2024. Jomana F. Musmar, Designated Federal Officer, Presidential Advisory Council on Combating AntibioticResistant Bacteria, Office of the Assistant Secretary for Health. [FR Doc. 2024–06157 Filed 3–22–24; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Solicitation of Nominations for Membership on the Secretary’s Advisory Committee on Human Research Protections; Correction Office of the Assistant Secretary for Health, Office for Infectious Disease and HIV/AIDS Policy, Office of the Secretary, Department of Health and Human Services (HHS). ACTION: Notice; correction. AGENCY: HHS published a document in the Federal Register of March 12, 2024, announcing the Presidential Advisory Council on HIV/AIDS (PACHA) 80th full council meeting. Due to unforeseen circumstances, there has been an update in meeting location. FOR FURTHER INFORMATION CONTACT: Caroline Talev, caroline.talev@hhs.gov, (202) 795–7622. SUPPLEMENTARY INFORMATION: SUMMARY: Correction In the Federal Register of March 12, 2024, in FR Doc. 2024–05183, on page 17859, third column, correct the ADDRESSES caption to read: ADDRESSES: The public meeting will now be held at the UT School of Public Health, 1200 Pressler Street in Houston, Texas 77030. To attend the meeting virtually, please visit www.hhs.gov/live. Dated: March 20, 2024. Caroline Talev, Senior Management Analyst, Office of Infectious Disease and HIV/AIDS Policy, Alternate Designated Federal Officer, Presidential Advisory Council on HIV/AIDS, Office of the Assistant Secretary for Health, Department of Health and Human Services. [FR Doc. 2024–06362 Filed 3–21–24; 4:15 pm] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\25MRN1.SGM 25MRN1

Agencies

[Federal Register Volume 89, Number 58 (Monday, March 25, 2024)]
[Notices]
[Page 20666]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-06362]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Solicitation of Nominations for Membership on the Secretary's 
Advisory Committee on Human Research Protections; Correction

AGENCY: Office of the Assistant Secretary for Health, Office for 
Infectious Disease and HIV/AIDS Policy, Office of the Secretary, 
Department of Health and Human Services (HHS).

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: HHS published a document in the Federal Register of March 12, 
2024, announcing the Presidential Advisory Council on HIV/AIDS (PACHA) 
80th full council meeting. Due to unforeseen circumstances, there has 
been an update in meeting location.

FOR FURTHER INFORMATION CONTACT: Caroline Talev, 
[email protected], (202) 795-7622.

SUPPLEMENTARY INFORMATION:

Correction

    In the Federal Register of March 12, 2024, in FR Doc. 2024-05183, 
on page 17859, third column, correct the addresses caption to read:

ADDRESSES: The public meeting will now be held at the UT School of 
Public Health, 1200 Pressler Street in Houston, Texas 77030. To attend 
the meeting virtually, please visit www.hhs.gov/live.

    Dated: March 20, 2024.
Caroline Talev,
Senior Management Analyst, Office of Infectious Disease and HIV/AIDS 
Policy, Alternate Designated Federal Officer, Presidential Advisory 
Council on HIV/AIDS, Office of the Assistant Secretary for Health, 
Department of Health and Human Services.
[FR Doc. 2024-06362 Filed 3-21-24; 4:15 pm]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.